Lehrstuhl für Innere Medizin IV

LONG-TERM RESULTS FROM THE SPYRAL HTN-ON MED TRIAL: RENAL DENERVATION INCREASES TIME IN BLOOD PRESSURE TARGET RANGE OVER 36 MONTHS (2022) Tsioufis K, Kandzari D, Kario K, Townsend R, Mahfoud F, Weber M, Schmieder R, et al. Journal article DETAILED ANALYSIS OF VASCULAR STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILURE (2022) Pietschner R, Kolwelter J, Bosch A, Striepe K, Kannenkeril D, Ott C, Schiffer M, et al. Journal article ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE (2022) Bosch A, Poglitsch M, Kannenkeril D, Ott C, Pietschner R, Striepe K, Schiffer M, Schmieder R Journal article IS BASAL NITRIC OXIDE ACTIVITY OF THE RENAL VASCULATURE ALTERED? ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL COMPARING TWO COMBINATION THERAPIES (2022) Kannenkeril D, Ott C, Bosch A, Striepe K, Pietschner R, Schiffer M, Schmieder R Journal article CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY (2022) Esler M, Cao K, Lobo M, Sharp AS, Kandzari DE, Mancia G, Böhm M, et al. Journal article DETAILED ANALYSIS OF VASCULAR STIFFNESS IN PATIENTS WITH CHRONIC HEART FAILURE (2022) Pietschner R, Kolwelter J, Bosch A, Striepe K, Kannenkeril D, Ott C, Schiffer M, et al. Conference contribution ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE (2022) Bosch A, Poglitsch M, Kannenkeril D, Ott C, Pietschner R, Striepe K, Schiffer M, Schmieder R Conference contribution Renal denervation in patients with chronic kidney disease: current evidence and future perspectives (2022) Schmieder R Journal article, Review article Peculiarities in the panoramic radiograph of patients with secondary hyperparathyroidism due to terminal renal disease: a radiologic controlled comparative study (2022) Möst T, Jahn AE, Heller KM, Schiffer M, Adler W, Rohde M, Weber M, et al. Journal article High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study (2022) Silbernagel G, Duarte K, Sadiku S, Fauler G, Maerz W, Schmieder R, Jardine AG, et al. Journal article